Cited by 139GDF15 and Related BiomarkersIron Metabolism and DisordersHemoglobinopathies and Related Disorders

Growth differentiation factor 15 in erythroid health and disease

Open access
Tanno, Toshihiko, Noel, Pierre, Miller, Jeffery L·2010·Current Opinion in Hematology

Abstract

PURPOSE OF REVIEW: Growth differentiation factor 15 (GDF15) was identified as a hepcidin-suppression factor that is expressed at high levels in patients with ineffective erythropoiesis. This review addresses the regulation, expression and potential functions of GDF15 in the context of erythroid biology. RECENT FINDINGS: GDF15 expression during late erythroid differentiation was discovered as part of an erythroblast transcriptome project. As GDF15 expression is associated with cellular stress or apoptosis, further investigation of the cytokine was focused upon its involvement in ineffective erythropoiesis. Remarkably high serum levels were detected in patients with thalassemia syndromes, congenital dyserythropoiesis and some acquired sideroblastic anemias. High-level GDF15 expression is not a feature of normal erythropoiesis, or erythroid recovery after bone-marrow transplantation. As GDF15 is a transforming growth factor-beta superfamily member, it was investigated as an effector of ineffective erythropoiesis that suppresses hepcidin expression despite iron overloading. SUMMARY: In contrast to the low levels of GDF15 expressed during normal erythropoiesis, ineffective erythropoiesis causes high-level expression of GDF15. In patients with thalassemia and related anemias, GDF15 expression may contribute to iron overloading or other features of the disease phenotype.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/moh.0b013e328337b52f

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased GDF15 serum levels associate with syndromes of ineffective erythropoiesis, for example α- and β-thalassemia.

    “While increased GDF15 serum levels associate with syndromes of ineffective erythropoiesis, for example α- and β-thalassemia”

    From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [216]

  • GDF-15 and TWSG1 are candidate erythrokines, although not erythroblast-specific, that have the potential to suppress hepcidin under conditions of increased erythropoietic activity.

    “Growth differentiation factor 15 (GDF-15) and twisted gastrulation homolog 1 (TWSG1) have been identified as candidate erythrokines, although not erythroblast-specific, that have the potential to suppress hepcidin under conditions of increased erythropoietic activity.”

    From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [216]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tanno, T., Noel, P., & Miller, J. L.
Affiliations
National Institutes of Health (US)
Venue
Current Opinion in Hematology
Published
2010-02
Volume
17
Issue
3
Pages
1
ISSN
1065-6251 (ISSN-L)
OpenAlex
W2128706348
Cited by
139
References
10
Citations by year
2026: 2 · 2025: 1 · 2024: 9 · 2023: 9 · 2022: 9 · 2021: 10 · 2020: 9 · 2019: 11 · 2018: 2 · 2017: 7 · 2016: 10 · 2015: 11 · 2014: 15 · 2013: 10 · 2012: 10
FWCI
7.59
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Hematology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (Z01DK025100)
Topics
  • Health Sciences › Medicine › Rheumatology › GDF15 and Related Biomarkers
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Genetics › Hemoglobinopathies and Related Disorders
Keywords
growth differentiation factor 15, GDF15, ineffective erythropoiesis, erythropoiesis, hepcidin, iron overload, thalassemia, congenital dyserythropoiesis, sideroblastic anemia, erythroblasts, apoptosis, bone marrow transplantation, TGF-beta superfamily
MeSH terms
Anemia, Animals, Erythropoiesis, Humans, Thalassemia, Iron Overload, Growth Differentiation Factor 15

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review